Concepedia

Author

Jieqi Zhou

First Affiliated Hospital of Soochow University

Also Known As

Jieqi Zhou

15

Publications

315

Citations

8

H-Index

16

Concepts

All Affiliations

First Affiliated Hospital of Soochow UniversitySoochow UniversitySuzhou Research InstituteNational Jewish HealthUniversity of Colorado Denver
JZ

About

Jieqi Zhou is an author at First Affiliated Hospital of Soochow University specializing in cell signaling, tumor biology, and molecular biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

27

2

Natural Sciences

1

1

27

3

Cell Biology

1

1

27

4

Molecular Biology

1

1

27

5

Pharmacology

1

1

27

Jieqi Zhou

×

8

Publications

308

Citations

8

H-Index

YearCitations

CD151 drives cancer progression depending on integrin α3β1 through EGFR signaling in non-small cell lung cancer

Jianjie Zhu, Tingting Cai, Jieqi Zhou,

Journal of Experimental & Clinical Cancer Research

2021

95

Integrin α3/α6 and αV are implicated in ADAM15-activated FAK and EGFR signalling pathway individually and promote non-small-cell lung cancer progression

Jieqi Zhou, Anqi Wang, Tingting Cai,

Cell Death and Disease

2022

72

ALCAP2 inhibits lung adenocarcinoma cell proliferation, migration and invasion via the ubiquitination of β-catenin by upregulating the E3 ligase NEDD4L

Weijie Zhang, Ruochen Zhang, Yuanyuan Zeng,

Cell Death and Disease

2021

27

EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells

Tingting Cai, Jieqi Zhou, Yuanyuan Zeng,

Journal of Experimental & Clinical Cancer Research

2020

25

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma

Yue Li, Ruoyi Shen, Anqi Wang,

Frontiers in Cell and Developmental Biology

2021

25

CPNE1 promotes non-small cell lung cancer progression by interacting with RACK1 via the MET signaling pathway

Anqi Wang, Wen Yang, Yue Li,

Cell Communication and Signaling

2022

24

The regulation of CPNE1 ubiquitination by the NEDD4L is involved in the pathogenesis of non-small cell lung cancer

Ruochen Zhang, Weijie Zhang, Yuanyuan Zeng,

Cell Death Discovery

2021

22

Advanced NSCLC Patients With EGFR T790M Harboring TP53 R273C or KRAS G12V Cannot Benefit From Osimertinib Based on a Clinical Multicentre Study by Tissue and Liquid Biopsy

Yulong Fu, Anqi Wang, Jieqi Zhou,

Frontiers in Oncology

2021

18

Page 1